Going global

June 2012
BioSpectrum;Jun2012, Vol. 10 Issue 6, p110
The article presents the corporate profile of Advanced Enzyme Technologies Ltd. (AETL) which focuses on manufacturing home-grown enzymes. AETL ranks 17th in the survey of the top 20 biotechnology companies conducted by the Association of Biotech led Enterprises (ABLE) from 2011-2012. The company attributes 60 percent of its business to its pharmaceutical and nutritional sectors. It predicts that its exports will account 70 percent of its business.


Related Articles

  • 'We rely every bit on our indigenous technology'. Som, Nayantara // BioSpectrum;Mar2012, Vol. 10 Issue 3, p62 

    An interview with chief executive officer (CEO) C. L. Rathi of Advanced Enzymes Technologies Ltd. (AETL) in India is presented. He discusses their strategies in achieving 30-35 percent growth for the company. Rathi reveals his plan regarding their export products for the U.S. and the European...

  • IndustryInsight BIOSPECTRUM ABLE SURVEY.  // BioSpectrum;Jul2014, Vol. 12 Issue 7, p62 

    The article presents the Biospectrum Able Survey that ranks several biotechnology companies in India. Included companies are Concord Biotech Ltd., Dr. Reddy's Laboratories Ltd. and Advanced Enzymes Technologies Ltd. Brief profiles on each company has been provided, along with information on...

  • Enzyme based cotton yarn singeing.  // Colourage;Feb96, Vol. 43 Issue 2, p60 

    Reports that Advanced Biochemicals Ltd. of Thane, India, has developed an enzyme-based cotton yarn singeing process which does not involve any capital investment. Other processes developed; Contact information.

  • Biotechnology: call for action. Mahadevan, Ajit // BioSpectrum;Sep2012, Vol. 10 Issue 9, p12 

    The article reports on the economic status of the biotechnology industry in India. While the industry recorded a 19.2 percent increase from 2007-2011, it has also been facing diverse challenges that prevented the industry from transcending to the next level. Details on the plan of the government...

  • India takes a backseat. Panwar, Anil // BioSpectrum;Jun2012, Vol. 10 Issue 6, p25 

    The author discusses the increase of clinical trials in India. He says that this condition is attributed to the country's established pharmaceutical and biotech industries environment and the ecosystem of contract research. He emphasizes that Indian clinical companies take advantage on low cost...

  • How can India Become a global manufacturing hub for biopharmaceuticals?  // BioSpectrum;Jul2012, Vol. 10 Issue 7, p104 

    The article focuses on the suggestions submitted by the Association of Biotech Led Enterprises (ABLE) to the Department of Biotechnology in India to make the nation a leading global biopharmaceutical manufacturer and supplier. The recommendations include the need for the industry to draw success...

  • Competition-driven market scenario.  // BioSpectrum;Aug2012, Vol. 10 Issue 8, p87 

    The article discusses the trends in India's bioprocess segment for the fiscal year 2011 to 2012. The market continues to grow by 20 percent which is dominated by the pharmaceutical sector. The application of single-use fluid devices and disposables becomes a continuing trend among the country's...

  • Fadex HB 2M - one step desizing and denim stonewashing. Roda, Deepak // Colourage;Apr2007, Vol. 54 Issue 4, p110 

    The article evaluates the Fadex HB 2M desizing and denim stonewashing agent and process from Advanced Enzyme Technologies Ltd.

  • New avenues in enzymatic textile processing.  // Colourage;Apr98, Vol. 45 Issue 4, p79 

    Reports that Advanced Biochemicals Ltd. has successfully commercialized enzyme-based technologies for yarn/fabric/garment processing.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics